Liu X - Search Results

1

Identification of a Functional ceRNA Network to Explore Potential Biomarkers for Hepatocellular Carcinoma.

Jiang Z, Zhang Y, Liu X, Liang J, Qiu G, Zhu X, Chen J, Li L. Jiang Z, et al. Among authors: liu x. Onco Targets Ther. 2020 Dec 1;13:12341-12355. doi: 10.2147/OTT.S278912. eCollection 2020. Onco Targets Ther. 2020. PMID: 33293827 Free PMC article.

2

Effects of miRNA-140 on the Growth and Clinical Prognosis of SMMC-7721 Hepatocellular Carcinoma Cell Line.

Kong CQ, Chen XC, Qiu GH, Liang JC, Wang D, Liu XY, Liu JJ, Han YQ, Fan XH. Kong CQ, et al. Biomed Res Int. 2021 Feb 5;2021:6638915. doi: 10.1155/2021/6638915. eCollection 2021. Biomed Res Int. 2021. PMID: 33628799 Free PMC article.

3

Signature of prognostic epithelial-mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma.

Xu BH, Jiang JH, Luo T, Jiang ZJ, Liu XY, Li LQ. Xu BH, et al. Medicine (Baltimore). 2021 Jul 30;100(30):e26762. doi: 10.1097/MD.0000000000026762. Medicine (Baltimore). 2021. PMID: 34397721 Free PMC article.

4

Circular RNA hsa_circ_0005218 promotes the early recurrence of hepatocellular carcinoma by targeting the miR-31-5p/CDK1 pathway.

Wang XB, Luo T, Lu SL, Lu HZ, Zhao TY, Jiang ZJ, Liu XY, Zhao C, Li LQ, Chen J. Wang XB, et al. Heliyon. 2023 Mar 22;9(4):e14816. doi: 10.1016/j.heliyon.2023.e14816. eCollection 2023 Apr. Heliyon. 2023. PMID: 37035389 Free PMC article.

5

Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization.

He K, Yang Z, Liu X, Yang Y, Song W, Wang S, Chen Y. He K, et al. Among authors: liu x. Curr Oncol. 2022 Dec 29;30(1):476-491. doi: 10.3390/curroncol30010038. Curr Oncol. 2022. PMID: 36661687 Free PMC article.

6

Sphingosine 1-phosphate receptor 2 promotes the onset and progression of non-alcoholic fatty liver disease-related hepatocellular carcinoma through the PI3K/AKT/mTOR pathway.

Wang G, Zhang X, Zhou Z, Song C, Jin W, Zhang H, Wu W, Yi Y, Cui H, Zhang P, Liu X, Xu W, Shen X, Shen W, Wang X. Wang G, et al. Among authors: liu x. Discov Oncol. 2023 Jan 11;14(1):4. doi: 10.1007/s12672-023-00611-8. Discov Oncol. 2023. PMID: 36631680 Free PMC article.

7

Development and Validation of a Vascular Endothelial Growth Factor A-associated Prognostic Model for Unresectable Hepatocellular Carcinoma.

He K, Liu X, Yang Z. He K, et al. Among authors: liu x. J Hepatocell Carcinoma. 2023 Feb 5;10:139-156. doi: 10.2147/JHC.S399299. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 36777498 Free PMC article.

8

FLNA promotes chemoresistance of colorectal cancer through inducing epithelial-mesenchymal transition and smad2 signaling pathway.

Cheng M, Jiang Y, Yang H, Zhao D, Li L, Liu X. Cheng M, et al. Among authors: liu x. Am J Cancer Res. 2020 Feb 1;10(2):403-423. eCollection 2020. Am J Cancer Res. 2020. PMID: 32195017 Free PMC article.

9

Comprehensive analysis of endoplasmic reticulum stress related signature in head and neck squamous carcinoma.

Miao Y, Chen Q, Liu X, Bu J, Zhang Z, Liu T, Yue Z, Huang L, Sun S, Li H, Yang A, Yang Z, Chen C. Miao Y, et al. Among authors: liu x, liu t. Sci Rep. 2024 Jul 23;14(1):16972. doi: 10.1038/s41598-024-65090-5. Sci Rep. 2024. PMID: 39043683 Free PMC article.

10

FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation.

Liu X, Jing X, Cheng X, Ma D, Jin Z, Yang W, Qiu W. Liu X, et al. Med Oncol. 2016 May;33(5):46. doi: 10.1007/s12032-016-0761-9. Epub 2016 Apr 4. Med Oncol. 2016. PMID: 27044356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136,827 results

Search Page

Filters